Inventiva annonce sa participation à la « 43rd Annual J.P. Morgan Healthcare Conference » Daix (France), New York City (New York, Etats Unis), le...
Daix (France), New York City (New York, United States), December 17, 2024 – Inventiva (Euronext Paris and...
Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference Daix (France), New York City (New York, United States), December 17...
Inventiva secures €21.4 million and completes the first tranche of the previously announced multi-tranche financing of up to €348 million...
Inventiva secures €21.4 million leading to completion of the first tranche of the financing for c. €116...
Inventiva obtient 21,4 millions d'euros complétant la première tranche du financement multi-tranches annoncé précédemment d'un montant...
Résultats des votes de l’Assemblée Générale Mixte des actionnaires – 11 décembre 2024 Daix (France), New York City (New York, Etats-Unis), le 11...
Results of the votes of the Combined Shareholders’ General Meeting of December 11, 2024 Daix (France), New York City (New York, United States...
Daix (France), New York City (New York, United States), December 11, 2024 – Inventiva (Euronext Paris and...
Inventiva publie ses informations financières du 3ème trimestre 2024¹ Trésorerie et équivalents de trésorerie à 13,9 millions d’euros au 30...
Inventiva reports 2024 Third Quarter Financial Information¹ Cash and cash equivalents at €13.9 million, as of September 30, 2024.Revenues of €1.3...
Cash and cash equivalents at €13.9 million, as of September 30, 2024.Revenues of €1.3 million for the first...
Statement of total voting rights and shares forming the company’s share capital as of November 4, 2024 Article R. 22-10-23 of the French...
Assemblée Générale Mixte du 11 décembre 2024 - Modalités de mise à disposition des documents préparatoires Daix (France), Long Island City (New...
Information relative au nombre total de droits de vote et d’actions composant le capital social au 4 novembre 2024 Article R. 22-10-23 du Code de...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads